In this study, using phage display technology and proteomic analysis for the first time, we isolated a human antibody strongly binding to the surface of HCT116 cells, a cetuximab-resistant CRC cell line, and identified the target antigen as human GRP94. The gene discussed is HSP90B1; the disease is colorectal carcinoma.